Stage III Verrucous Carcinoma of the Larynx Active Not Recruiting Phase 2 Trials for DB01229 (Paclitaxel)

IndicationStatusPhase
DBCOND0029516 (Stage III Verrucous Carcinoma of the Larynx)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02048020Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx CancerTreatment